Fairness opinions › Acquirers
Centene: healthcare acquisitions with fairness opinions
3 public-company targets, 2015-2021, $25B combined enterprise value. The multiples Centene paid and the banker analyses behind each target board's recommendation.
Deals
3
Median EV / EBITDA paid
14.5x
Median EV / revenue paid
0.45x
| Announced | Target | Acquirer | Segment | EV | EV/EBITDA | EV/Rev | DCF rate | Fairness opinion |
|---|---|---|---|---|---|---|---|---|
| 2021-01-04 | Magellan Health | Centene | Managed Care | $2.0B | 15.6x | 0.45x | 7.0%–8.0% | Goldman Sachs, Guggenheim Securities |
| 2019-03-27 | WellCare Health Plans | Centene | Managed Care | $17B | 14.5x | 0.62x | 7.0%–8.3% | Goldman Sachs, Allen, Barclays |
| 2015-07-02 | Health Net | Centene | Managed Care | $6.0B | 9.3x | 0.37x | 8.0%–9.0% | J.P. Morgan, Allen |